Searched for
UNAPPROVED MEDICINES
CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
Root cause: India’s spice crown under threat as quality concerns trace back to farmsFarm-level traceability, quality, value addition, and branding are key to converting export scale into global trust, according to experts.
India tightens grip on GLP-1 supply chain amid misuse concerns, expands crackdown on unapproved drugsIndia's drug regulator is increasing checks on weight loss drug sales. This action follows inspections of pharmacies and clinics nationwide...
India’s drug regulator flags 90 unapproved FDCs, directs states to take actionIndia's drug regulator has initiated a nationwide crackdown on unapproved fixed-dose combination drugs. At least 90 such medicines have bee...
Are your eye drops safe? CDSCO flags illegal products, doctors issue strong warning on irritation, conjunctivitisAuthorities have launched a major crackdown on unapproved dry eye relief drops being sold without mandatory CDSCO approval. States and Unio...
Delhi HC stops drug body from taking action against IndiaMartThe Delhi High Court has temporarily blocked the CDSCO from pursuing criminal action against IndiaMart for allegedly listing unapproved med...
Stricter shelf life rule a bitter pill to swallow for pharma companiesA new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...
Lancet report on unapproved antibiotic use in India is 'misleading, inappropriate': Govt officialProf. Y K Gupta, a senior pharmacologist and vice chairman of the Standing National Committee on Medicines (SNCM) which prepared the Nation...
Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet studyThe data were gathered from a panel of 9,000 stockists who store products from approximately 5,000 pharmaceutical companies.
Centre must take action against Ramdev for making unscientific statements against allopathy: IMARamdev should be prosecuted under the Epidemic Diseases Act as "untutored" statements are "a threat to the literate society of the country ...
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19A bench led by CJI S.A. Bobde issued notices to the central government on a petition filed by lawyer Manoharlal Sharma claiming that these ...
Awaiting critical Remdesivir safety data from companies: DCGIApart from BDR, all have entered into voluntary licensing agreements with Gilead Science, US-based patent holder of this drug. Gilead said ...
Novartis, U.S. regulators agree to malaria drug hydroxychloroquine trial against COVID-19Novartis has reached an agreement with U.S. regulators to hold a randomized trial of generic malaria drug hydroxychloroquine against COVID-...
Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...
Madras High Court bans online sales of medicinesThe court set January 31, 2019 as the deadline for the central government to notify the rules.
‘Banned ingredients in diet pills putting Indians at risk’Several dietary supplements, most of which are widely available in India, have been found adulterated with unapproved and even banned pharm...
64% of antibiotics sold in India unapproved, finds UK studyThe report said millions of antibiotic pills in the Indian market have not been regulated in India, the UK or US, worsening the problem of ...
Strides Arcolab working with USFDA on import alert on unit's productsThe company further wishes to clarify that it has no role in the distribution of any of these products in the US territory, Strides said.
- US Department of Justice to withdraw motion against Ranbaxy
Department Of Justice to withdraw motion to subpoena if company submits all audit documents in frauds case.
- Ranbaxy refutes DoJ's adulteration charges
Ranbaxy has refuted the charges levelled against it by US Department of Justice of not sharing audit information sought by US authorities. ...